NUZ 2.17% 23.5¢ neurizon therapeutics limited

Ann: Dr Kim Agnew appointed Principal Investigator of dog trial, page-34

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 12,294 Posts.
    lightbulb Created with Sketch. 6309
    Dr Agnew has been with us for two months now ,,, plus he is armed with the latest K9 Phase IIb Positive data. that coupled with the previous 2 K9 Trials and the Beagle Phase I and what with the interested companies making themselves know to Roger directly after Elanco Declined the Option,,,, can't see it being to long until a commercial partner is announced for a Phase III.....
    Pretty much a red day across the sector except those who announced positive data ,,,, good to see Scientific Progress being rewarded... PAA's turn must be just around the corner?
 
watchlist Created with Sketch. Add NUZ (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.